Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Insulin symbols : LLY save search
Global Insulin Pen Market Projected to Reach $73.39 Billion by 2028 with Steady CAGR of 5.25% during 2023-2028
Published: 2023-07-28 (Crawled : 19:00) - prnewswire.com
TRUMY | $16.507 0.79% 34K
|
Manufacturing
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
reach global insulin market
UAE Human Insulin Market Report 2023: Featuring Novo Nordisk Pharma, Sanofi, Baxter, Eli Lilly & More
Published: 2023-02-21 (Crawled : 02:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.38%
H: 1.4%
C: 0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
report insulin market
Insulin Drugs Global Market Report 2023
Published: 2023-02-20 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
global report insulin market
Lilly and IABL Collaborate to Ensure Patient Access to High-Quality Affordable Insulin in Bangladesh
Published: 2023-02-13 (Crawled : 18:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.39%
H: 1.25%
C: 1.13%
insulin
Smart Insulin Pens Market Size to Reach USD 302.1 Million in 2030 | Emergen Research
Published: 2023-02-06 (Crawled : 18:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.61%
H: 0.88%
C: 0.33%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.31%
H: 0.08%
C: -1.83%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.86%
H: 0.42%
C: -1.26%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
research smart insulin market
Global Insulin Pen Market Analysis & Forecasts, 2021-2022 & 2023-2027: Focus on United States, India, China, Brazil, Saudi Arabia, United Kingdom, Germany, Netherlands, Sweden, Switzerland, Australia
Published: 2022-12-22 (Crawled : 20:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: 3.99%
H: 0.0%
C: -0.64%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: -1.16%
H: 2.28%
C: 1.1%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.04%
H: 0.33%
C: 0.33%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.13%
H: 0.84%
C: 0.84%
global australia insulin market
Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa
Published: 2022-12-14 (Crawled : 10:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.1%
H: 2.9%
C: 1.25%
pharma collaboration insulin africa
Human Insulin Market is expected to generate a revenue of USD 63.64 Billion by 2028, Globally, at 7.65% CAGR: Verified Market Research®
Published: 2022-11-15 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.59%
H: 0.37%
C: -0.1%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.25%
H: 0.01%
C: -1.96%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: -1.71%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
research expected insulin market
Insulin Market is Likely to Upsurge USD 25.12 Billion Globally by 2029, Size, Share, Trends, Demand, Market Dynamics, Growth Forecast and Challenges
Published: 2022-11-07 (Crawled : 10:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.01%
H: 0.88%
C: 0.88%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.91%
H: 1.82%
C: 1.43%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
insulin growth market
Global Insulin Delivery Devices Market Report 2022-2030: Growing Diabetic Population & Surge in the Launch of Insulin Delivery Devices
Published: 2022-10-17 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.18%
H: 1.26%
C: 0.93%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 1.46%
H: 0.94%
C: -0.05%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.42%
H: 1.44%
C: -0.01%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.74%
H: 1.69%
C: 1.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.51%
H: 0.95%
C: 0.65%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: -0.52%
H: 4.35%
C: 1.9%
global report growing insulin market diabetic
$9.3 Billion Worldwide Rapid Acting Insulin Industry to 2027 - Featuring Adocia, Biocon Limited and Geropharm Among Others
Published: 2022-08-23 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.66%
H: 0.0%
C: -1.69%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.01%
H: 2.53%
C: 2.2%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.43%
H: 1.39%
C: 0.76%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.48%
H: 0.0%
C: 0.0%
MNKD | $4.19 2.7% 2.63% 1.8M
|
Health Technology
|
| O: -0.77%
H: 4.94%
C: 3.64%
rapid insulin
Global Smart Insulin or Glucose Responsive Insulin Market (2022 to 2027) - Featuring AstraZeneca, Biocon and Dongbao Enterprise Among Others
Published: 2022-08-16 (Crawled : 15:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 4.78%
H: 1.14%
C: 1.14%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.0%
H: 0.14%
C: -1.15%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.28%
H: 1.13%
C: 0.65%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
global smart insulin market
Insulin Market Size Worth $111.21 Billion by 2028 at 10.8% CAGR Lead by Biosimilar Insulin Segment (Register 16% CAGR) Global Analysis by The Insight Partners
Published: 2022-08-08 (Crawled : 12:00) - prnewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.02%
H: 0.24%
C: -0.62%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.22%
H: 1.82%
C: 0.62%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
global biosimilar insulin market
Eli Lilly Q2: Down 4% as Government Pushes on Insulin Prices, Forced to Pay $61 Million Fine
Published: 2022-08-04 (Crawled : 15:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.16%
H: 0.02%
C: -1.42%
insulin
Insulin Market to Exceed US$ 30 Bn by 2031; Global Burden of Diabetes and Complications Propelling Adoption of Therapies, Observes TMR Report
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
report diabetes insulin market
Insulin Delivery Devices Market to Hit $39,371.8 Million Revenue by 2030, says P&S Intelligence
Published: 2022-03-18 (Crawled : 07:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 2.46%
H: 0.6%
C: 0.41%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.12%
H: 1.93%
C: 0.63%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.68%
H: 0.55%
C: 0.24%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.62%
H: 1.07%
C: 0.89%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: -0.35%
H: 5.54%
C: 5.11%
device liver intel insulin
At 9.7% CAGR, Insulin Delivery Devices Market Size to hit USD 33.05 Billion in 2028, Says Brandessence Market Research
Published: 2022-01-03 (Crawled : 12:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.78%
H: 0.0%
C: 0.0%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
ce mark device research liver insulin
Global $19 Billion Home-Use Insulin Delivery Devices Markets, 2015-2020 & 2021-2030
Published: 2021-12-20 (Crawled : 19:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.2%
H: 1.62%
C: 1.37%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.45%
H: 2.78%
C: 1.68%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.2%
H: 0.74%
C: 0.33%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.57%
H: 0.63%
C: -0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.76%
H: 0.67%
C: 0.45%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 0.29%
H: 3.22%
C: 3.08%
device liver insulin
United States Insulin Syringes Market Report 2021: Market Value, Volume, and Pricing Analysis & Forecasts 2019-2027
Published: 2021-10-21 (Crawled : 14:15) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: -1.54%
RVP P | $1.06 0.95% 0.0% 84K
|
Health Technology
|
| O: 1.2%
H: 0.39%
C: -0.79%
insulin
Tirzepatide results published in The Lancet show superior A1C and body weight reductions compared to insulin glargine in adults with type 2 diabetes with increased cardiovascular risk
Published: 2021-10-19 (Crawled : 11:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.03%
H: 1.46%
C: 1.36%
diabetes risk cardiovascular results insulin cardio glargine lancet tirzepatide
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.